Owens & Minor EBITDA Margin 2010-2025 | OMI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Owens & Minor (OMI) over the last 10 years. The current EBITDA margin for Owens & Minor as of June 30, 2025 is .
| Owens & Minor EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $10.74B | $0.39B | 3.60% |
| 2025-03-31 | $10.72B | $0.34B | 3.19% |
| 2024-12-31 | $10.70B | $0.37B | 3.41% |
| 2024-09-30 | $8.65B | $0.38B | 4.42% |
| 2024-06-30 | $8.52B | $0.39B | 4.61% |
| 2024-03-31 | $10.42B | $0.40B | 3.79% |
| 2023-12-31 | $10.33B | $0.39B | 3.79% |
| 2023-09-30 | $10.23B | $0.28B | 2.75% |
| 2023-06-30 | $10.13B | $0.30B | 2.98% |
| 2023-03-31 | $10.07B | $0.37B | 3.64% |
| 2022-12-31 | $9.96B | $0.37B | 3.73% |
| 2022-09-30 | $9.87B | $0.44B | 4.42% |
| 2022-06-30 | $9.88B | $0.40B | 4.09% |
| 2022-03-31 | $9.87B | $0.38B | 3.80% |
| 2021-12-31 | $9.79B | $0.46B | 4.70% |
| 2021-09-30 | $9.68B | $0.49B | 5.10% |
| 2021-06-30 | $9.37B | $0.50B | 5.38% |
| 2021-03-31 | $8.69B | $0.43B | 4.97% |
| 2020-12-31 | $8.48B | $0.30B | 3.50% |
| 2020-09-30 | $8.31B | $0.22B | 2.66% |
| 2020-06-30 | $8.42B | $0.18B | 2.14% |
| 2020-03-31 | $8.98B | $0.18B | 1.99% |
| 2019-12-31 | $9.21B | $0.19B | 2.05% |
| 2019-09-30 | $9.14B | $0.22B | 2.44% |
| 2019-06-30 | $9.32B | $0.22B | 2.35% |
| 2019-03-31 | $9.40B | $0.19B | 2.04% |
| 2018-12-31 | $9.42B | $0.19B | 2.01% |
| 2018-09-30 | $9.69B | $0.12B | 1.26% |
| 2018-06-30 | $9.56B | $0.12B | 1.22% |
| 2018-03-31 | $9.36B | $0.14B | 1.53% |
| 2017-12-31 | $9.32B | $0.15B | 1.60% |
| 2017-09-30 | $9.30B | $0.20B | 2.16% |
| 2017-06-30 | $9.38B | $0.22B | 2.37% |
| 2017-03-31 | $9.60B | $0.24B | 2.53% |
| 2016-12-31 | $9.72B | $0.25B | 2.61% |
| 2016-09-30 | $9.84B | $0.26B | 2.68% |
| 2016-06-30 | $9.90B | $0.27B | 2.69% |
| 2016-03-31 | $9.84B | $0.27B | 2.69% |
| 2015-12-31 | $9.77B | $0.27B | 2.72% |
| 2015-09-30 | $9.78B | $0.26B | 2.63% |
| 2015-06-30 | $9.69B | $0.24B | 2.45% |
| 2015-03-31 | $9.58B | $0.22B | 2.33% |
| 2014-12-31 | $9.44B | $0.22B | 2.36% |
| 2014-09-30 | $9.27B | $0.22B | 2.42% |
| 2014-06-30 | $9.15B | $0.24B | 2.59% |
| 2014-03-31 | $9.08B | $0.25B | 2.73% |
| 2013-12-31 | $9.07B | $0.25B | 2.74% |
| 2013-09-30 | $9.04B | $0.24B | 2.68% |
| 2013-06-30 | $8.95B | $0.24B | 2.65% |
| 2013-03-31 | $8.90B | $0.24B | 2.66% |
| 2012-12-31 | $8.87B | $0.24B | 2.66% |
| 2012-09-30 | $8.78B | $0.23B | 2.63% |
| 2012-06-30 | $8.78B | $0.24B | 2.75% |
| 2012-03-31 | $8.72B | $0.24B | 2.73% |
| 2011-12-31 | $8.63B | $0.24B | 2.76% |
| 2011-09-30 | $8.50B | $0.23B | 2.74% |
| 2011-06-30 | $8.39B | $0.23B | 2.73% |
| 2011-03-31 | $8.28B | $0.23B | 2.77% |
| 2010-12-31 | $8.12B | $0.23B | 2.77% |
| 2010-09-30 | $8.09B | $0.24B | 2.97% |
| 2010-06-30 | $8.07B | $0.24B | 2.98% |
| 2010-03-31 | $8.06B | $0.24B | 2.93% |
| 2009-12-31 | $8.04B | $0.23B | 2.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.414B | $10.701B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.435B | 26.79 |
| Boston Scientific (BSX) | United States | $153.732B | 36.66 |
| Stryker (SYK) | United States | $149.077B | 30.35 |
| EssilorLuxottica (ESLOY) | France | $146.011B | 0.00 |
| Medtronic (MDT) | Ireland | $115.234B | 16.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.493B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.717B | 24.97 |
| ResMed (RMD) | United States | $41.881B | 29.95 |
| Agilent Technologies (A) | United States | $34.119B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $33.772B | 15.87 |
| Terumo (TRUMY) | Japan | $27.820B | 32.97 |
| Koninklijke Philips (PHG) | Netherlands | $26.548B | 17.56 |
| Insulet (PODD) | United States | $23.052B | 77.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.663B | 13.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.153B | 0.00 |
| Baxter (BAX) | United States | $12.496B | 9.65 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.804B | 28.67 |
| Lantheus Holdings (LNTH) | United States | $3.750B | 10.14 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.442B | 24.08 |
| Perrigo (PRGO) | Ireland | $3.247B | 8.11 |
| Prestige Consumer Healthcare (PBH) | United States | $3.219B | 14.28 |
| ICU Medical (ICUI) | United States | $3.055B | 20.80 |
| Haemonetics (HAE) | United States | $2.616B | 11.68 |
| LeMaitre Vascular (LMAT) | United States | $2.158B | 46.28 |
| QuidelOrtho (QDEL) | United States | $1.816B | 11.43 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.676B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.566B | 67.25 |
| Phibro Animal Health (PAHC) | United States | $1.291B | 16.50 |
| AdaptHealth (AHCO) | United States | $1.279B | 18.17 |
| Neogen (NEOG) | United States | $1.219B | 19.34 |
| Acuren (TIC) | United States | $1.209B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 2454.00 |
| Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
| Valneva SE (VALN) | France | $0.975B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 8.29 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| SNDL (SNDL) | Canada | $0.552B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.534B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.501B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.10 |
| Evolus (EOLS) | United States | $0.461B | 0.00 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.300B | 0.00 |
| Omeros (OMER) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Brainsway (BWAY) | Israel | $0.273B | 55.65 |
| Viemed Healthcare (VMD) | United States | $0.270B | 20.44 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.262B | 0.00 |
| High Tide (HITI) | Canada | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| Cerus (CERS) | United States | $0.228B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.38 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.053B | 31.05 |
| Veru (VERU) | United States | $0.047B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.98 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |